Showing 5221-5230 of 5956 results for "".
- Gilead Says Early Results of Coronavirus Drug Trial Show Improvement With Shorter Remdesivir Treatmenthttps://modernod.com/news/gilead-says-early-results-of-coronavirus-drug-trial-show-improvement-with-shorter-remdesivir-treatment/2477673/Gilead Sciences said Wednesday preliminary results of a coronavirus drug trial showed at least 50% of patients treated with a five-day dosage of remdesivir improved and more than half were discharged from the hospital within two weeks, according to a CNBC
- AAPS: Hydroxychloroquine Has about 90 Percent Chance of Helping COVID-19 Patientshttps://modernod.com/news/aaps-hydroxychloroquine-has-about-90-percent-chance-of-helping-covid-19-patients/2477670/In a letter to Gov. Doug Ducey of Arizona, the Association of American Physicians and Surgeons (AAPS) presented a
- Widely Used Surgical Masks Are Putting Health Care Workers At Serious Riskhttps://modernod.com/news/widely-used-surgical-masks-are-putting-health-care-workers-at-serious-risk/2477666/With medical supplies in high demand, federal authorities say health workers can wear surgical masks for protection while treating COVID-19 patients—but growing evidence suggests the practice is putting workers in jeopardy, according to a
- Congress Urges FDA to Better Police, Evaluate COVID-19 Antibody Testshttps://modernod.com/news/congress-urges-fda-to-better-police-evaluate-covid-19-antibody-tests/2477665/Members of Congress have called on the FDA to re-evaluate its stance toward COVID-19 antibody tests. Since mid-March, the agency has allowed diagnostic developers to bring their products to market without any outside evaluation that the results they produce are accurate, according to a
- Clearside Biomedical Revises NDA Resubmission Timeline and Xipere Commercial Partnership with Bausch Healthhttps://modernod.com/news/clearside-biomedical-revises-nda-resubmission-timeline-and-xipere-commercial-partnership-with-bausch-health/2477660/Clearside Biomedical announced an update to the Xipere (triamcinolone acetonide suprachoroidal injectable suspension) new drug application (NDA) resubmission timeline and to its commercialization and development partnership with Bausch Health Companies and Bausch + Lomb.
- New Dates Announced for BMC Virtual Spring Symposiumhttps://modernod.com/news/new-dates-announced-for-bmc-virtual-spring-symposium/2477658/Bryn Mawr Communications (BMC) has announced that its first virtual educational initiative, the BMC Virtual Spring Symposium, will now be held on May 29-30. The BMC Virtual Spring Symposium is designed to enable discussion, engagement, and live Q&A for members of the vision community w
- Foundation Fighting Blindness To Jointly Host Online CME, COPE Webinarhttps://modernod.com/news/foundation-fighting-blindness-to-jointly-host-online-cme-cope-webinar/2477657/The Foundation Fighting Blindness has announced it will host its first continuing medical education (CME and COPE) event. The distance-learning course will be hosted on Monday, May 18, 2020 at 12 pm eastern time. The course will cover inherited retinal diseases (IRDs), Foundation resources, and c
- I-MED Pharma Gains Health Canada Approval For E>Eye Laserhttps://modernod.com/news/i-med-pharma-gains-health-canada-approval-for-eeye-laser/2477656/I-MED Pharma has announced Health Canada approval for dry eye device E>Eye Laser, which is now available to Canadian eye care professionals. E>Eye, designed and manufactured in France by E-Swin, is the only CE certified medical device using patented IRPL technology developed specifi
- Market Scope: COVID-19 Fallout Could Reshape Ophthalmology in Indiahttps://modernod.com/news/market-scope-covid-19-fallout-could-reshape-ophthalmology-in-india/2477647/Market Scope estimates the total ophthalmic market in India in 2020 at $1.3 billion, with an optimistic assumption that the COVID-19 suspension of elective surgeries will last for 2 months or less. The firms forecasts a rapid return to 2019 levels of activity, resulting in an overall 25 percent r
- COVID-19 Vaccine Protects Monkeys From New Coronavirus, Chinese Biotech Reportshttps://modernod.com/news/covid-19-vaccine-protects-monkeys-from-new-coronavirus-chinese-biotech-reports/2477646/For the first time, one of the many COVID-19 vaccines in development has protected an animal, rhesus macaques, from infection by the new coronavirus, according to a